MMRF Expert Offers Update on Multiple Myeloma Trials
While the Multiple Myeloma Research Foundation (MMRF) is solely focused on ensuring patients are equipped with precisely what they need to treat their ...
curetoday
Advances in Multiple Myeloma: What’s New in 2019?
Presented by Dr. Tiedemann, on April 6, 2019 at the Toronto & District Multiple Myeloma Support Group meeting. Advances in Multiple Myeloma: What's New in ...
Myeloma Canada
Multiple myeloma patient hopeful for cure
Update June 2020: In memory of Myron Gill. Doctors diagnosed Myron Gill with multiple myeloma more than 20 years ago. He has faith that researchers at IU ...
Indiana University School of Medicine
CAR T-cells for multiple myeloma: update & what's in store for ASH 2018
CAR T-cells have gone from strength to strength in the field of hem-onc, and it looks like the next malignancy they are set to revolutionize treatment for is multiple ...
VJHemOnc – Video Journal of Hematological Oncology
Novel small molecules in multiple myeloma: Update on key results from emerging clinical studies
In this presentation from the Great Debates & Updates in Hematologic Malignancies 2018 conference, Dr. Paul G. Richardson provides an update on key results ...
ImedexCME
Updates in Multiple Myeloma
This Best of the Day activity features a videotaped conversation between Dr. Jim Epstein and Dr. Ruben Niesvizky highlighting the key points presented for ...
ImedexCME
Multiple Myeloma (Updated 2018) -- CRASH! Medical Review Series
For just $1/month, you can help keep these videos free! Subscribe to my Patreon at http://www.patreon.com/pwbmd (Disclaimer: The medical information ...
Paul Bolin, M.D.
Frontline Therapy for Multiple Myeloma - PFS Webinar 031420
Listen to the replay of the IMF Patient & Family Webinar. This features a panel discussion about the latest updates on Frontline Therapy for multiple myeloma led ...
International Myeloma Foundation
Carfilzomib for relapsed multiple myeloma: clinical trial updates
The selective proteasome inhibitor carfilzomib has previously shown efficacy in terms of progression-free survival (PFS) for relapsed multiple myeloma (MM).
VJHemOnc – Video Journal of Hematological Oncology
Update on recent smoldering multiple myeloma trials
Clinical trials in smoldering multiple myeloma (SMM) have produce many exciting results, with new drug approvals and standards of care arising from recent ...
VJHemOnc – Video Journal of Hematological Oncology
Multiple Myeloma Background, Shared Decision Making, and Smoldering MM Research Update
Recorded at the IMF Satellite Symposium that was held at the April 2019 Oncology Nursing Society's annual meeting, this video is the first in a five-part series on ...
International Myeloma Foundation
Multiple Myeloma Therapies Update
Dr. Patrick Hagen from Loyola University Medical Center delivered this presentation at the Leukemia Research Foundation Treatment Options for Blood Cancer ...
Leukemia Research Foundation
Updates on German clinical trials in multiple myeloma
Marc Raab, MD, PhD, of University Hospital Heidelberg, Heidelberg, Germany, gives an overview of recently concluded and ongoing German clinical trials ...
VJHemOnc – Video Journal of Hematological Oncology
Updates on multiple myeloma management
Elena Zamagni, MD, PhD, University of Bologna, Bologna, Italy, outlines the latest advances in the management of multiple myeloma (MM), including newly ...
VJHemOnc – Video Journal of Hematological Oncology
Post autologous transplant therapies in high risk multiple myeloma: StaMINA trial update
Dr Krishnan speaks with ecancer at the 16th International Myeloma Workshop about the StaMINA trial, which looked at autologous haematopoietic cell ...
ecancer
Surviving Multiple Myeloma - Mayo Clinic
Multiple myeloma is a type of cancer for which there is no cure. But treatment for this disease has improved greatly in recent years. Patients can live in remission ...
Mayo Clinic
Dr. Berdeja on Updated Data With bb21217 in Multiple Myeloma
Website: https://www.onclive.com Twitter: https://twitter.com/OncLive Facebook: https://www.facebook.com/OncLive/ LinkedIn: ...
OncLiveTV
Coronavirus (COVID-19) and Multiple Myeloma - PFS Webinar 031420
Listen to the replay of the IMF Patient & Family Webinar. This features a panel discussion about the latest updates on COVID-19 and how it impacts myeloma ...
International Myeloma Foundation
Dr. Lonial Discusses Recent Updates in Multiple Myeloma
OncLiveTV
International Research Group Publishes Updated Criteria for Diagnosing Multiple Myeloma
The International Myeloma Working Group (IMWG) today announced that it has updated the criteria for diagnosing multiple myeloma. A paper outlining the new ...
Mayo Clinic
An update on immunotherapy for multiple myeloma in 2016
Jesús San Miguel, MD, PhD from the University Clinic of Navarra, Pamplona, Spain introduces the round table discussion on immunotherapy at the 2016 ...
VJHemOnc – Video Journal of Hematological Oncology
Ola Landgren - Newly Updated IMWG Criteria for the Diagnosis of Multiple Myeloma; the Importance of
Watch on LabRoots at http://new.labroots.com/webinar/id/77 The International Myeloma Working Group (IMWG) has issued updated criteria for the diagnosis of ...
LabRoots
Multiple myeloma -- blood cancer formed in bone marrow
Multiple myeloma is a cancer caused by malignant plasma cells. Plasma cells help the human body fight infection, but when they multiply out of control, the ...
MD Anderson Cancer Center
VCDI for multiple myeloma: an update
VCD (bortezomib, cyclophosphamide and dexamethasone) is an effective chemotherapy combination commonly used for the treatment of newly diagnosed ...
VJHemOnc – Video Journal of Hematological Oncology
Updates in Multiple Myeloma Research - 2018
Presented by Dr Anca Prica, member of the Myeloma Program team at Princess Margaret Cancer Centre in Toronto.
Myeloma Canada
The Importance of Bone Health and Treatment Updates in Multiple Myeloma
Join Dr. Noopur Raje and Beth Faiman as they discuss the importance of bone health and treatment updates for multiple myeloma patients. Please subscribe to ...
International Myeloma Foundation
Updates in the Treatment of Relapsed/Refractory Multiple Myeloma
Natalie S. Callander, MD, Professor of Medicine, University of Wisconsin Carbone Cancer Center, discusses updates in the treatment of relapsed/refractory ...
Targeted Oncology
Dr. Pecora on Updated MAIA Data in Multiple Myeloma
Andrew Pecora, MD, FACP, CPE, president physician enterprise, chief innovation officer, John Theurer Cancer Center, Hackensack Meridian Health, discusses ...
OncLiveTV
Treatment Options for Multiple Myeloma - Mayo Clinic
In the third of a four-part video series on multiple myeloma, Vivek Roy, M.D., hematologist and director of the bone marrow transplant program at Mayo Clinic in ...
Mayo Clinic
Update on trametinib for multiple myeloma
Faith Davies, MBBCh, MRCP, MD, FRCPath from UAMS Myeloma Institute, Arkansas, AZ gives an update on the use of trametinib, which is a MEK inhibitor, ...
VJHemOnc – Video Journal of Hematological Oncology
Frontline Treatment with RVd for Multiple Myeloma
Robert A. Vescio, MD, rationalizes the choice of the triplet regimen of RVd as a frontline therapy option for multiple myeloma with high-risk cytogenetics and ...
Targeted Oncology
Updated risk stratification model for smoldering multiple myeloma
Updated risk stratification model for smoldering multiple myeloma (SMM) incorporating the revised IMWG diagnostic criteria Maria-Victoria Mateos, MD PhD ...
International Myeloma Foundation
Stem Cell Transplantation as a Treatment for Multiple Myeloma - Mayo Clinic
Multiple myeloma is a cancer of the plasma cells, which are found in the bone marrow or blood-producing tissue that fills spaces within the bones. In this video ...
Mayo Clinic
Emerging Immunotherapies in Multiple Myeloma
Earn CME: https://naccme.com/program/7328 In this presentation from the 'Updates on Treatment Approaches Across the Multiple Myeloma Spectrum' ...
ImedexCME
Optimizing Frontline Therapy in Multiple Myeloma
Sagar Lonial, MD, FACP, shares insight into the optimal approaches to transplant and maintenance therapy as methods to improve the frontline management of ...
AJMCtv
Upcoming updates in multiple myeloma
Thierry Facon, MD, of Lille University Hospital, Lille, France, discusses trial results and what the future holds for multiple myeloma. This interview took place at ...
VJHemOnc – Video Journal of Hematological Oncology
Plasma Cell Dyscrasias (an intro to Multiple Myeloma)
Animated Mnemonics (Picmonic): https://www.picmonic.com/viphookup/medicosis/ - With Picmonic, get your life back by studying less and remembering more.
Medicosis Perfectionalis
2019 Multiple Myeloma Symposium | Diagnosis, Prognosis & Risk
In this insightful talk, Nikhil C. Munshi, MD discusses the complex and advanced diagnostic methods for multiple myeloma and shares insight on prognosis, risk, ...
Dana-Farber Cancer Institute
Stem Cell Transplants for Multiple Myeloma Patients
Autologous Stem Cell Transplant is not always the best treatment option. Please consult your healthcare professional if you have any questions about your ...
Sanofi Genzyme
Updated MAIA Trial Data Show Improved Survival for Multiple Myeloma
Nizar Bahlis, MD, University of Calgary, discusses the findings from the randomized phase III MAIA trial, which evaluated the combination regimen of ...
Targeted Oncology
Multiple Myeloma: Combination Therapy for Relapsed/Refractory Patients
Earn CME for related activities: https://www.naccme.com/oln In this presentation from the 2019 Great Debates & Updates in Hematologic Malignancies - Los ...
ImedexCME
COVID-19: treating patients with multiple myeloma
Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone Medical Center, New York, NY, updates us on the impact of COVID-19 on treating patients with ...
VJHemOnc – Video Journal of Hematological Oncology
